305 related articles for article (PubMed ID: 24528633)
1. The relationship between advanced oxidation protein products (AOPP) and biochemical and histopathological findings in patients with nonalcoholic steatohepatitis.
Ozenirler S; Erkan G; Konca Degertekin C; Ercin U; Cengiz M; Bilgihan A; Yilmaz G; Akyol G
J Dig Dis; 2014 Mar; 15(3):131-6. PubMed ID: 24528633
[TBL] [Abstract][Full Text] [Related]
2. Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH.
Boga S; Koksal AR; Alkim H; Yilmaz Ozguven MB; Bayram M; Ergun M; Sisman G; Tekin Neijmann S; Alkim C
Metab Syndr Relat Disord; 2015 Nov; 13(9):393-9. PubMed ID: 26367098
[TBL] [Abstract][Full Text] [Related]
3. [The significance of 8-hydroxy-deoxyguanosine acid in the diagnosis of nonalcoholic steatohepatitis].
Jiang Y; Han T; Zhang ZG; Lu SQ; Mi YQ; Xu L; Qi FX; Zhang Y; Song GD
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):34-38. PubMed ID: 28056321
[No Abstract] [Full Text] [Related]
4. Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
Tanwar S; Trembling PM; Guha IN; Parkes J; Kaye P; Burt AD; Ryder SD; Aithal GP; Day CP; Rosenberg WM
Hepatology; 2013 Jan; 57(1):103-11. PubMed ID: 22930399
[TBL] [Abstract][Full Text] [Related]
5. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
Kim TH; Jun HY; Kim KJ; Lee YH; Lee MS; Choi KH; Yun KJ; Jeong YY; Jun CH; Cho EY; Yoon KH
J Magn Reson Imaging; 2017 Nov; 46(5):1298-1310. PubMed ID: 28225569
[TBL] [Abstract][Full Text] [Related]
6. Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.
Arab JP; Hernández-Rocha C; Morales C; Vargas JI; Solís N; Pizarro M; Robles C; Sandoval D; Ponthus S; Benítez C; Barrera F; Soza A; Riquelme A; Arrese M
Gastroenterol Hepatol; 2017; 40(6):388-394. PubMed ID: 28359548
[TBL] [Abstract][Full Text] [Related]
7. Advanced oxidation protein products, total thiol levels and total oxidant/antioxidant status in patients with nash.
Başkol M; Dolbun Seçkin K; Başkol G
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():32-7. PubMed ID: 25910362
[TBL] [Abstract][Full Text] [Related]
8. The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease.
Malik R; Chang M; Bhaskar K; Nasser I; Curry M; Schuppan D; Byrnes V; Afdhal N
J Gastroenterol Hepatol; 2009 Apr; 24(4):564-8. PubMed ID: 19378390
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
Verma S; Jensen D; Hart J; Mohanty SR
Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
[TBL] [Abstract][Full Text] [Related]
10. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
[TBL] [Abstract][Full Text] [Related]
11. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
[TBL] [Abstract][Full Text] [Related]
12. [Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis].
Yang M; Liu Y; Zhou G; Guo X; Zou S; Liu S; Jiang L; Liu Y; Zhu L; Guo C; Zhao J
Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):96-101. PubMed ID: 26983475
[TBL] [Abstract][Full Text] [Related]
13. The value of ultrasonography and computerized tomography in estimating the histopathological severity of nonalcoholic steatohepatitis.
Ataseven H; Yildirim MH; Yalniz M; Bahcecioglu IH; Celebi S; Ozercan IH
Acta Gastroenterol Belg; 2005; 68(2):221-5. PubMed ID: 16013637
[TBL] [Abstract][Full Text] [Related]
14. Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis.
Lupsor M; Badea R; Stefanescu H; Grigorescu M; Serban A; Radu C; Crişan D; Sparchez Z; Iancu S; Maniu A
J Gastrointestin Liver Dis; 2010 Mar; 19(1):53-60. PubMed ID: 20361076
[TBL] [Abstract][Full Text] [Related]
15. Could inflammatory markers help diagnose nonalcoholic steatohepatitis?
Tarantino G; Conca P; Pasanisi F; Ariello M; Mastrolia M; Arena A; Tarantino M; Scopacasa F; Vecchione R
Eur J Gastroenterol Hepatol; 2009 May; 21(5):504-11. PubMed ID: 19318968
[TBL] [Abstract][Full Text] [Related]
16. Serum liver fatty acid binding protein shows good correlation with liver histology in NASH.
Özenirler S; Degertekin CK; Erkan G; Elbeğ Ş; Tuncer C; Kandilc U; Akyol G
Hepatogastroenterology; 2013; 60(125):1095-100. PubMed ID: 23803374
[TBL] [Abstract][Full Text] [Related]
17. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study.
Abdel-Razik A; Mousa N; Shabana W; Refaey M; ElMahdy Y; Elhelaly R; Elzehery R; Zalata K; Arafa M; Elbaz S; Hafez M; Awad M
Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):e1-9. PubMed ID: 26469357
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of nitrate, nitrite and advanced oxidation protein products (AOPP) in patients with nonalcoholic fatty liver disease.
Çiftci A; Yilmaz B; Köklü S; Yüksel O; Özsoy M; Erden G; Öztürk G; Akbal E; Ergül B; Koçak E; Cesur S
Acta Gastroenterol Belg; 2015 Jun; 78(2):201-5. PubMed ID: 26151688
[TBL] [Abstract][Full Text] [Related]
19. Association between endotoxemia and histological features of nonalcoholic fatty liver disease.
Kitabatake H; Tanaka N; Fujimori N; Komatsu M; Okubo A; Kakegawa K; Kimura T; Sugiura A; Yamazaki T; Shibata S; Ichikawa Y; Joshita S; Umemura T; Matsumoto A; Koinuma M; Sano K; Aoyama T; Tanaka E
World J Gastroenterol; 2017 Jan; 23(4):712-722. PubMed ID: 28216979
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis.
Kayadibi H; Gültepe M; Yasar B; Ince AT; Ozcan O; Ipcioglu OM; Kurdas OO; Bolat B; Benek YZ; Guveli H; Atalay S; Ozkara S; Keskin O
Dig Dis Sci; 2009 Aug; 54(8):1764-71. PubMed ID: 18989777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]